Nifty 100 News, Corporate filings and Earnings/Conference Calls

Keep track of all breaking news and updates on Nifty 100 from all sources in a single place.

Load latest

Indian Railway Finance Corporation Ltd.

22 Apr 2025, 06:01PM

132.50

0.14%

Company Update

Indian Railway Finance Corporation Ltd - 543257 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet …

BSE India

Intimation of Conference Call with Analyst & Investor on Audited Financial Results for the Q4FY24-25 & Year Ended 31st March 2025

pdf

HCL Technologies Ltd.

22 Apr 2025, 06:00PM

1594.90

7.77%

Result

HCL Technologies Ltd - 532281 - Consolidated Financial Results - IFRS For The Year Ended March …

BSE India

Enclosed please find the Consolidated Financial Statements - IFRS for the year ended March 31 2025.

pdf

	Mar 2025	Dec 2024	Mar 2024	Change QoQ%	Change YoY%
Total Revenue Qtr	30695.00	30367.00	28915.00	1.1%	6.2%
Operating Profit Qtr	6482.00	6860.00	6117.00	-5.5%	6.0%
Net Profit Qtr	4307.00	4591.00	3986.00	-6.2%	8.1%
Earning Per Share Adjusted latest Qtr	15.87	16.92	14.69	-6.2%	8.0%

* Consolidated data

Detailed Results

HCL Technologies Ltd.

22 Apr 2025, 05:55PM

1594.90

7.77%

Corp. Action

HCL Technologies Ltd - 532281 - Corporate Action-Board approves Dividend

BSE India

The Board of Directors has declared an Interim Dividend of Rs. 18/- per equity share of Rs. 2 each of the Company for the financial year 2025-25.

pdf

Swiggy Ltd.

22 Apr 2025, 05:49PM

349.05

1.66%

Company Update

Swiggy Ltd - 544285 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS

BSE India

The Finance and General Management Committee at its meeting held on Tuesday, April 22, 2025, have approved the allotment of 36,32,264 Equity Shares of the Company pursuant to exercise of stock options by the eligible employees, under Swiggy ESOP Plan 2015 and Swiggy ESOP Plan 2021

pdf

Havells India Ltd.

22 Apr 2025, 05:49PM

1615.00

-2.99%

to see Rapid results content

HCL Technologies Ltd.

22 Apr 2025, 05:48PM

1594.90

7.77%

Company Update

HCL Technologies Ltd - 532281 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

BSE India

Enclosed please find the Investor Release for Q4 FY 2025.

pdf

HCL Technologies Ltd.

22 Apr 2025, 05:45PM

1594.90

7.77%

Board Meeting

HCL Technologies Ltd - 532281 - Board Meeting Outcome for Outcome Of Board Meeting

BSE India

Enclosed please find Outcome for Board Meeting - Audited Financial Results for the quarter and year ended March 31, 2025.

pdf

Dr. Reddy's Laboratories Ltd.

22 Apr 2025, 05:45PM

1186.70

1.00%

Dr Reddy's, Lupin recall products in US due to manufacturing errors: USFDA

Business Standard

Dr Reddy's Laboratories and Lupin are recalling products in the US market due to labelling and manufacturing errors, respectively, according to the US health regulator. As per its latest Enforcement Report, US Food and Drug Administration (USFDA) said a US-based subsidiary of the Hyderabad-based drug major is recalling certain batches of a generic antiepileptic drug in the US market. Princeton-based Dr Reddy's Laboratories, Inc is recalling 4,010 bags of Levetiracetam 0.75 pc in Sodium Chloride Injection (1,000 mg/100 mL) in the US due to labelling mix up, USFDA said. "The infusion bag is incorrectly labelled as Levetiracetam in 0.82% Sodium Chloride Injection 500 mg/100 mL, while the aluminum overwrap packaging correctly identifies the product as Levetiracetam in 0.75% Sodium Chloride Injection 1,000 mg/100 mL," it added. The company has issued the Class 1 nationwide (US) recall on March 13 this year, the US health regulator noted. As per the USFDA, a Class I recall pertains to .